PolyCypher’s mission is to proactively predict and prevent common diseases based on the unique makeup of each individual. To do so, we’re developing a predictive analytics platform based on genomics, health data and AI. Our team has decades of combined experience at the nexus of biotech, genomics, technology, and business. We have massive market opportunities, in both health and biopharma. In the health sector, our model is B2B2C, targeting health enterprises and their members. We are nearing completion of our first commercial platform, and in discussion with several potential partners. We are now raising a pre-seed round of $1M and seeking additional partnerships.